Related by context. All words. (Click for frequent words.) 77 vapreotide acetate 76 Tezampanel 75 Pegloticase 75 Pirfenidone 75 Dasatinib 75 Noxafil 75 Meets Primary Endpoint 75 Initiates Enrollment 75 Zorbtive TM 75 Epratuzumab 75 Eculizumab 75 Oral Fingolimod 75 Fondaparinux 74 Peginterferon alfa 2b 74 Bosutinib 74 R lenalidomide 74 PEGylated anti 74 sorafenib tablets 74 Psoriasis Drug 74 panitumumab Vectibix 74 Febuxostat 74 Phase 2b Clinical Trial 74 R sorafenib tablets 74 Receives Orphan Drug Designation 74 AVASTIN 74 STELARA TM 74 SPRYCEL ® 74 Aflibercept 74 YONDELIS 74 Ambrisentan 74 R Saizen R 74 ZOLINZA 74 thalidomide Thalomid 73 phase III isavuconazole 73 Belimumab 73 Completes Patient Enrollment 73 adalimumab Humira 73 Boceprevir 73 docetaxel Taxotere ® 73 Eltrombopag 73 TEMODAL 73 Methylnaltrexone 73 FDA Accepts 73 Aliskiren 73 Vitrasert R 73 Golimumab 73 PROCRIT ® 73 Long Term Efficacy 73 dual endothelin receptor antagonist 73 efalizumab 73 Certolizumab pegol 73 Recombinant Human 73 Mirapexin 73 SUTENT ® 73 Pazopanib 73 Granulocyte Colony Stimulating Factor 73 Vicriviroc 73 methylnaltrexone bromide 73 Investigational Compound 73 novel synthetic PEGylated 73 TNF Tumor Necrosis Factor 73 chronic idiopathic thrombocytopenic purpura 73 selective modulator 73 Mg Usa 73 Silodosin 73 peptidic compound 73 Crofelemer budesonide foam 73 dasatinib Sprycel ® 73 Zarnestra 73 Tasigna nilotinib 73 Liprotamase 72 Initiate Clinical Trial 72 Vidaza azacitidine 72 Mylan Receives Approval 72 Desvenlafaxine 72 etanercept Enbrel 72 Receives Approvable Letter 72 memantine HCl 72 myelodysplastic myeloproliferative diseases 72 Clolar ® 72 sorafenib Nexavar 72 Pivotal Phase III 72 humanized therapeutic 72 LymphoStat B belimumab 72 Denufosol 72 Antitumor Activity 72 NDA Submission 72 Raptiva R 72 Initiates Phase III 72 Cutaneous T 72 Sodium oxybate 72 PEGylated Fab fragment 72 Degarelix 72 rasagiline tablets 72 Achieves Primary Endpoint 72 Temsirolimus 72 Ixempra 72 developing Bicifadine serotonin 72 Phase IIb Trial 72 Pemetrexed 72 Muraglitazar 72 MAGE A3 ASCI 72 Torisel 72 Romidepsin 72 Ocrelizumab 72 Novel Oral 72 FDA APPROVES 72 ADP receptor antagonist 72 Vimpat R 72 nilotinib Tasigna 72 Submits NDA 72 Ticagrelor 72 FOLOTYN ® 72 Glufosfamide 72 PRN FDA Approves 72 Kuvan sapropterin dihydrochloride 72 Dementia Related Psychosis 72 Receives Positive Opinion 72 Ustekinumab 72 sunitinib Sutent 72 Anidulafungin 72 Vandetanib 72 Prolongs Survival 72 GW# [003] 72 Complicated Skin 71 gastrointestinal stromal tumors GIST 71 Serostim ® 71 Talabostat 71 RANK Ligand inhibitor 71 Expanded Indication 71 Phase 2a Trial 71 Rivaroxaban 71 mTOR mammalian target 71 interferon gamma 1b 71 Sapacitabine 71 cetuximab Erbitux R 71 investigational monoclonal antibody 71 TYZEKA 71 Patients Treated With 71 Yondelis ® 71 levetiracetam Keppra 71 Mg Uk 71 hypereosinophilic syndrome 71 Combination REOLYSIN R 71 Blinatumomab 71 Etravirine 71 Phase 2b Trial 71 peptibody 71 Gleevec imatinib mesylate 71 Initiates Clinical 71 erlotinib Tarceva R 71 octreotide acetate 71 Friedreich Ataxia FRDA 71 Hsp# Inhibitor 71 Gamunex C 71 Fludara ® 71 Angiox ® 71 Tesamorelin 71 Everolimus 71 Azacitidine 71 Receives Marketing Authorization 71 R memantine HCl 71 Kit CD# positive 71 Gout Drug 71 Ramelteon 71 Lenalidomide 71 Adalimumab 71 Etanercept 71 Humira adalimumab 71 Plicera 71 Fluconazole 71 Granted Orphan Drug 71 erlotinib Tarceva ® 71 Study Evaluating 71 ® lenalidomide 71 TO AVOID PREGNANCY WHILE 71 pregabalin Lyrica 71 Known hypersensitivity 71 Dalbavancin 71 INSPIRE Trial Phase III 71 sapropterin dihydrochloride 71 Dabigatran etexilate 71 Announces Tentative Approval 71 Clinical Trial Results 71 chronic eosinophilic leukemia 71 Carfilzomib 71 CYP#A# substrate 71 markets HP Acthar 71 Shows Efficacy 71 Nexavar sorafenib 71 Amgen Nplate 71 Initiates Phase II 71 oral prodrug 71 Ovitrelle R Serostim 71 Alexion Pharma 71 Belatacept 71 Bazedoxifene 71 Hematological Malignancies 71 aripiprazole Abilify 71 romiplostim 71 Dose Ranging Study 71 Orphan Status 71 Investigational Treatment 71 Interferon beta 1b 71 Patient Enrollment 71 Refractory Hodgkin Lymphoma 71 Lambert Eaton Myasthenic 71 Files IND 71 Remicade infliximab 71 Lubiprostone 71 Regeneron Pharma 71 xanthine oxidase inhibitor 71 Pivotal Trial 71 acetonide FA 71 Xyrem ® 71 NAVISTAR R 71 Monopril 71 ARIXTRA R 71 oncolytic virus therapies 71 Personalized Immunotherapy 71 Therapeutic Competitors Companies 70 ACE Inhibitors 70 Positive Opinion 70 Panzem R 70 Deforolimus 70 RoACTEMRA 70 pseudobulbar affect PBA 70 Tyrosine Kinase Inhibitor 70 pemetrexed Alimta 70 Begins Dosing 70 pan HDAC inhibitor 70 GTC recombinant form 70 dasatinib Sprycel 70 alfa 2a 70 Certican 70 Safinamide 70 Generic Versions 70 Plaque Psoriasis 70 oral dual endothelin 70 Pulmonary Arterial Hypertension 70 Pegintron 70 Advanced Melanoma 70 Torisel temsirolimus 70 Submits Response 70 Inhalation Solution 70 icatibant 70 Gel repository corticotropin injection 70 eltrombopag 70 ® darbepoetin alfa 70 Glatiramer Acetate 70 non peptidic protease 70 Abatacept 70 Fast Track Status 70 Trobalt 70 Initiates Clinical Trial 70 Microwave Ablation System 70 humanized interleukin 6 70 Eszopiclone 70 Severe Sepsis 70 Omalizumab 70 Sanvar R 70 Nexavar ® 70 Elagolix 70 idiopathic thrombocytopenic purpura ITP 70 Telbivudine 70 Generic Version 70 Alemtuzumab 70 Intravitreal 70 Firazyr 70 Azathioprine 70 Previously Treated 70 histamine dihydrochloride 70 ANDA Filing 70 Velcade bortezomib 70 ONGLYZA ™ 70 Toremifene 70 Paliperidone Palmitate 70 Phase III Trial 70 TRANSDUR ® 70 darbepoetin alfa Aranesp 70 Aztreonam Lysine 70 Tarceva TM 70 PROVENGE ® 70 NV1FGF 70 mTOR inhibitor 70 Warfarin Coumadin 70 investigational humanized monoclonal antibody 70 Antithrombin 70 Prostate Cancer Vaccine 70 Drug Candidate 70 refractory chronic lymphocytic 70 Bucindolol 70 First Patient Enrolled 70 ACTEMRA TM 70 AstraZeneca Iressa 70 sunitinib malate 70 myelofibrosis polycythemia vera 70 Myelofibrosis 70 Mycophenolate Mofetil 70 Phase 2a Clinical Trial 70 lucinactant 70 Montelukast 70 Dacogen injection 70 Epidermal Growth Factor Receptor 70 Initiate Phase 70 Elotuzumab 70 Maribavir 70 Amrubicin 70 PDUFA Date 70 Submits Biologics License Application 70 sunitinib Sutent ® 70 imatinib Gleevec ® 70 Efficacy Results 70 MKC# MT 70 Enzyme Replacement Therapy 70 Roche Actemra 70 pediatric Crohn disease 70 Fulvestrant 70 Rheumatoid Arthritis Drug 70 Phase III Clinical Trial 70 AstraZeneca Symbicort 70 Valsartan 70 omalizumab Xolair 70 VIVITROL ® 70 Adjuvant Treatment 70 Tacrolimus 70 Sprycel dasatinib 70 gefitinib Iressa 70 docetaxel Taxotere R 70 Xcytrin R 70 Hycamtin 70 Newly Diagnosed Multiple Myeloma 70 Vidaza R 70 Schizophrenia Drug 70 Celebrex celecoxib 70 Genentech Rituxan 70 efaproxiral 70 Biogen Genentech 70 posaconazole 70 Saforis 70 Moxifloxacin 70 Bifeprunox 70 Bafetinib 70 ribavirin USP 70 rHuPH# recombinant human 70 Hedgehog Pathway Inhibitor 70 Dupuytren Contracture 70 CYT# potent vascular disrupting 70 BCG refractory carcinoma 70 Certolizumab 70 Pregabalin 70 metastatic malignant 70 Starlix 69 IG HCR ;) CO 69 Ropinirole 69 Pivotal Clinical Trial 69 Renal Impairment 69 nasal calcitonin product 69 Hormone Refractory Prostate Cancer 69 Pafuramidine 69 pan histone deacetylase 69 Interferon beta 1a 69 Levoleucovorin 69 pralatrexate injection folate analogue 69 BRILINTA 69 Phase III Pivotal 69 Known generically 69 Pramlintide 69 Anti Tumor 69 MEVACOR 69 midstage clinical 69 oxaliplatin Eloxatin 69 investigational pharmacologically unique 69 Mipomersen 69 rituximab Rituxan 69 Taxotere chemotherapy 69 Cholesterol Lowering Drug 69 diarrhea predominant irritable 69 IL# PE#QQR 69 Civacir 69 IMiDs 69 MGd 69 Aviptadil 69 FDA Approvable Letter 69 Teriparatide 69 Xelox 69 Bevacizumab 69 GTC recombinant human 69 Demonstrates Significant 69 vildagliptin 69 Orencia abatacept 69 kidney urologic 69 Neupro R 69 recurrent glioblastoma multiforme 69 monoclonal antibody IgG1 Mab 69 Arranon 69 RECOTHROM R 69 Tipranavir 69 Reminyl galantamine 69 selective A2A adenosine receptor 69 Wafer polifeprosan 69 pioglitazone HCl 69 Sycrest 69 cetuximab Erbitux 69 Clofarabine 69 UPLYSO 69 targeted antifolate 69 RAPAMUNE 69 Pivotal Phase 69 basiliximab 69 refractory gout 69 Hydrochlorothiazide Tablets 69 Presents Positive 69 IgG1 monoclonal antibody 69 Phase IIb Clinical Trial 69 ergot derivatives 69 biologic antibody 69 Vertex hepatitis C 69 Epilepsy Drug 69 Trabectedin 69 CYP#A# CYP#D# 69 SinuNase TM 69 Lung Cancer Drug 69 balsalazide disodium Capsules 69 Doripenem 69 rilonacept 69 2 methoxyestradiol 69 Kepivance 69 Mycamine 69 5 Fluorouracil 69 topical gel formulation 69 Kidney Transplant Patients 69 Ixabepilone 69 ® bortezomib 69 Files Investigational 69 LymphoStat B TM 69 Therapeutic Competitors companiesandmarkets.com adEgemonye 69 Exelon rivastigmine 69 Fabry Disease 69 Enzastaurin 69 Rilonacept 69 beta 1a 69 Simulect 69 generation purine nucleoside 69 essential thrombocythemia ET 69 Natalizumab 69 Tanespimycin 69 5 HT6 receptor 69 proteasome inhibitor 69 formerly LymphoStat B 69 Launches Generic Version 69 PROCRIT R 69 cromolyn sodium 69 Fast Track designations 69 Archexin 69 small molecule thrombopoietin 69 Coadministration 69 Ecallantide 69 receptor tyrosine kinase inhibitor 69 PEGINTRON TM 69 Relapsed Multiple Myeloma 69 Bayer Onyx 69 Teva Provides Update 69 Fingolimod 69 Vildagliptin 69 RhuDex 69 SABER ™ 69 MyVax R 69 Angiotensin Converting Enzyme 69 Peginterferon 69 PROMACTA 69 Investigational Drug 69 Avastin bevacizumab 69 Aryplase 69 Demonstrates Positive 69 nucleoside analog 69 PKC# 69 ALN HPN 69 REVLIMID R 69 Calcitonin 69 Prochymal TM 69 Tasimelteon 69 DORIBAX 69 Orphan Designation 69 Immunomedics Announces 69 Ridaforolimus 69 JAK2 Inhibitor 69 SNT-MC#/idebenone 69 Sipuleucel T 69 FASLODEX 69 mycophenolic acid 69 BARACLUDE R 69 Traficet EN 69 Generic Version Of 69 Blood Pressure Drug 69 esophageal candidiasis 69 Sandimmune 69 Ranolazine 69 Ribavirin causes 69 Myelodysplastic Syndromes 69 Tigecycline 69 Camptosar ® 69 Tibotec Therapeutics division 69 Rituxan rituximab 69 Presents Preclinical Data 69 Revlimid lenalidomide 69 Cethrin R 69 Anemia Drug 69 AAG geldanamycin analog 69 visilizumab 69 REMINYL ® 69 erlotinib Tarceva 69 Zoloft sertraline 69 Ofatumumab 69 COLAZAL R 69 palifermin 69 Adentri 69 Nebulized 68 Ovidrel 68 Syndrome LEMS 68 NOXAFIL 68 Dapagliflozin 68 Pivotal Study 68 Rasilamlo 68 Advanced Renal Cell 68 Drug Fails 68 FDA Approvals 68 TYGACIL 68 Bayer Nexavar 68 Vaprisol 68 Pooled Analysis 68 mertansine 68 Danazol 68 Egrifta 68 R bendamustine hydrochloride 68 Campath alemtuzumab 68 Successfully Completes Phase 68 thetreatment 68 Supplemental Biologics License Application 68 Pertuzumab 68 Demonstrate Significant 68 Kuvan R 68 LAF# 68 Erythropoietin 68 Sugammadex 68 IAP inhibitor 68 reslizumab 68 Myelodysplastic Syndrome MDS 68 Cimzia ® certolizumab pegol 68 sitaxsentan 68 opioid receptor antagonist 68 SYCREST 68 cinacalcet 68 Diabetic Macular Edema 68 lexidronam injection 68 carcinoma mCRC 68 Lacosamide 68 Emtriva Viread 68 Vidofludimus 68 liver resection surgeries 68 Increlex R 68 dihydrochloride 68 severe hypercholesterolemia 68 JAK Inhibitor 68 See CLINICAL PHARMACOLOGY 68 Laquinimod 68 Preclinical Data 68 Demonstrates Sustained 68 Perforomist ™ Inhalation Solution 68 combines bupropion 68 Receives Orphan Drug 68 Betaferon R 68 CIMZIA TM 68 Promacta 68 sodium glucose cotransporter 68 Tocilizumab 68 BAY #-# 68 Receptor Antagonists 68 Zevalin R Ibritumomab 68 Cimzia certolizumab pegol 68 chimeric monoclonal antibody 68 IMiDs ® compound 68 cediranib 68 histone deacetylase HDAC inhibitor 68 HCV Protease Inhibitor 68 Pegylated 68 markets COLAZAL 68 epoetin zeta 68 alefacept 68 treat chronic sinusitis 68 Anti Tumor Activity 68 Genasense ® oblimersen 68 RAPTIVA 68 Nilotinib 68 Loceryl ® 68 Zenpep 68 Posaconazole 68 Brentuximab Vedotin SGN 68 Phase IIa Clinical Trial 68 Lansoprazole 68 HDAC Inhibitor 68 CONBRIZA 68 corticotropin injection 68 autologous cellular immunotherapy 68 mild vasodilator 68 Amgen Neulasta R 68 Cyclooxygenase 2 68 Chronic Lymphocytic Leukemia 68 Completes Enrollment 68 investigational antiplatelet agent 68 Pyridorin 68 Tekamlo 68 induced macular edema 68 candesartan cilexetil 68 INTEGRILIN R 68 Navelbine ® 68 Pralatrexate 68 Eraxis 68 adult chronic ITP 68 evaluating tivozanib 68 SomatoKine 68 lamotrigine Lamictal 68 MKC# MKC# PP 68 PDX pralatrexate 68 cutaneous T 68 Demonstrates Efficacy 68 Lupus Nephritis 68 infliximab Remicade 68 Treatment Experienced 68 NICE Recommends 68 albiglutide 68 TRANSDUR ™ 68 carbamazepine Tegretol 68 Inhalation Aerosol 68 Bicalutamide 68 INVANZ 68 Taxotere docetaxel 68 Xeloda ® 68 PRISTIQ 68 sertraline Zoloft 68 tenofovir disoproxil fumarate Viread 68 raloxifene Evista 68 alfuzosin 68 Afinitor everolimus 68 purpura ITP 68 intranasal formulation 68 First Patient Treated 68 LEUKINE 68 PF # [002] 68 develop HBV reactivation 68 norepinephrine reuptake inhibitor 68 INVEGA ® 68 acyclovir Lauriad R 68 Application MAA 68 Revolade 68 Fludarabine 68 benzoic acid hyoscyamine sulfate 68 virus HCV protease inhibitor 68 Campath ® 68 Arthritis Drug 68 Aeolus Pharmaceuticals Announces 68 Naproxcinod 68 anti CD3 antibody 68 Receives Fast Track 68 Cetrorelix 68 Gemzar gemcitabine 68 Angioedema 68 guanfacine extended release 68 Amgen Vectibix 68 inhibitor PPI 68 Pixuvri 68 teriflunomide 68 Ceflatonin R 68 FUSILEV enhances 68 pentadentate logo R 68 protein tyrosine phosphatase 1B 68 mapatumumab 68 Receives Complete Response 68 Tolvaptan 68 Aptivus ® 68 Paliperidone ER 68 dextromethorphan quinidine 68 itraconazole Sporanox 68 Interferon Beta 68 Cethromycin 68 TORISEL TM 68 C1 Inhibitor 68 Randomized Double blind 68 granted Ortec 68 Vectibix panitumumab 68 Thiazolidinediones 68 reversing heparin 68 Plasmin 68 Single Dose 68 Bivalirudin 68 CIMZIA R 68 Nipent R 68 Product Characteristics 68 Nitazoxanide 68 Zileuton 68 ORENCIA R 68 EVIZON TM 68 Myelodysplastic Syndromes MDS 68 Fluticasone 68 Esbriet ® 68 hyaluronidase enzyme 68 rheumatoid arthritis juvenile idiopathic 68 MOVIPREP R 68 Immunotherapeutic 68 Atypical Hemolytic Uremic Syndrome 68 FUSILEV ® 68 baminercept 68 Panitumumab 68 liposomal formulation 68 BAL# [002] 68 Catena ® 68 Decitabine 68 Sebivo 68 bortezomib Velcade 68 Candesartan 68 targeting CD# 68 TNF Blockers 68 Carbamazepine 68 Erlotinib 68 Zemplar 68 Arimoclomol 68 D aspartate NMDA receptor 68 Actimmune ® 68 Ganciclovir 68 r hGH 68 arsenic trioxide injection 68 Novel Antibiotic 68 delivers fluocinolone acetonide FA 68 Capsules CII 68 Enbrel etanercept 68 Otelixizumab 68 HuMax TAC 68 Tygacil 68 Kineret R 68 Serdolect ® 68 Rebif ® 68 Vernakalant 68 Soriatane 68 mu opioid receptor antagonist 68 GAMMAGARD LIQUID 68 serotonin norepinephrine reuptake inhibitor 68 XYOTAX TM 68 CRMD# 68 administered concomitantly 68 Vaccine Adjuvant 68 Keppra ® levetiracetam 68 PROCRIT 68 Removab 68 Entereg R 68 Gleevec Glivec 68 markets Gelclair R 68 Femara letrozole 68 colesevelam HCl 68 Bezielle 68 topically applied SEPA 68 cancer neuroendocrine tumor 68 sitagliptin metformin 68 Zenvia Phase III 68 Improves Survival 68 Voreloxin 67 benign prostatic hypertrophy BPH 67 Copegus ® 67 Icatibant 67 IMiDs R 67 Preclinical Study 67 soluble tumor necrosis 67 Inhaled Insulin 67 Daptomycin 67 Telik logo TELINTRA 67 phenyl salicylate methylene blue 67 brand ciclesonide HFA 67 Rivastigmine 67 Paraplatin ® 67 Drug Shows Promise 67 de novo kidney transplant 67 Onyx Pharmaceuticals Announces 67 Cancidas 67 non constipation irritable 67 pioglitazone hydrochloride 67 II Clinical Trial 67 Phase 1b Clinical Trial 67 Acute Attacks 67 rivastigmine Exelon 67 personalized cellular immunotherapy 67 Neuvenge 67 diabetic neuropathic pain 67 TELINTRA 67 FDA Okays 67 Brilique 67 BRIM2 67 targeted radiotherapeutic 67 PHRM 67 non porcine pancreatic 67 Saxagliptin 67 Melphalan 67 Treated Patients 67 Copegus ribavirin 67 Sodium Injection 67 LEVADEX TM 67 Bortezomib 67 ImClone Erbitux 67 inhalation powder 67 Taro Receives 67 oxypurinol 67 indinavir Crixivan 67 Castration Resistant Prostate Cancer 67 vandetanib 67 OMP #R# 67 temsirolimus Torisel 67 Retacrit 67 arthritis PsA 67 Randomized Phase 67 Migraine Drug 67 Improved Survival 67 iloprost synthetic compound 67 TRACON Pharmaceuticals 67 Adjunctive Therapy 67 Cimzia R 67 fosbretabulin 67 MBRX 67 Ziprasidone 67 THALOMID R 67 paclitaxel Taxol R 67 R metformin Concor 67 Late Breaker 67 Lilly Cymbalta 67 TransVax 67 Saquinavir 67 novel histone deacetylase 67 Irinotecan 67 Atomoxetine 67 Marketing Authorisation Application 67 BARACLUDE ® 67 TYKERB 67 Annamycin 67 non nucleoside inhibitor 67 interferon beta 1a infertility 67 Panzem 67 secondary hyperparathyroidism 67 Bendamustine 67 leukotriene receptor antagonist 67 telomerase therapeutic 67 Iloperidone 67 OMNARIS 67 Relapsing Remitting Multiple Sclerosis 67 bone marrow reticulin deposition 67 immunosuppressant drug 67 Zolinza 67 SUSTENNA TM 67 phase IIb trial 67 onabotulinumtoxinA 67 Auxilium Pharma 67 AEGR 67 Initiate Phase III 67 nelfinavir Viracept 67 Presents Preclinical 67 Janus kinase 67 Atacicept 67 ticagrelor Brilinta 67 VISICOL R 67 Varespladib 67 Risperidone Oral Solution 67 Pruvel TM 67 Atripla combines 67 Clevudine 67 rheumatoid arthritis psoriatic arthritis 67 metastatic colorectal 67 #I TM# 67 paclitaxel Taxol ® 67 Xenazine ® 67 Evoltra ® 67 urocortin 2 67 Cloretazine 67 Gleevec imatinib 67 ABILIFY ® 67 Neulasta ® 67 Lamotrigine 67 Alteplase 67 Drug Eluting Stent System 67 Calcium Acetate 67 #mg Tablets [002] 67 ISTODAX 67 DPP4 67 Aprotinin 67 alvimopan 67 Temodar ® 67 Combination Treatment 67 IV Busulfex 67 Clinical Trial Data 67 Protease Inhibitor 67 PROVENGE sipuleucel T 67 Neulasta R 67 Raptiva ® 67 MERREM 67 Zelapar 67 dopamine receptor agonist 67 Teriflunomide 67 Cariprazine 67 Regenerative Cells 67 antibody MAb 67 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 67 herpetic keratitis 67 MetroGel 67 Celgene Revlimid 67 TLK# 67 SPL# Gel vaginal microbicide 67 imatinib Gleevec 67 Metastatic Melanoma 67 Dose Escalation 67 Roflumilast 67 mild hepatic impairment 67 ixabepilone 67 ATPace TM 67 Factor Xa inhibitor 67 Metabasis Therapeutics 67 Neoadjuvant 67 post herpetic neuralgia PHN 67 oropharyngeal candidiasis OPC 67 HuMax EGFr 67 By JAMAAL ABDUL 67 nucleotide analogue 67 familial amyloidotic polyneuropathy FAP 67 SNT MC# 67 Shows Statistically Significant 67 Nasdaq DVAX 67 VAPRISOL 67 esomeprazole Nexium 67 fentanyl buccal tablet 67 Actemra tocilizumab 67 OMP designation 67 Budesonide foam crofelemer 67 investigational oral inhibitor 67 Hydrochlorothiazide 67 Antiplatelet 67 PRIALT 67 catheter occlusion 67 Dexilant 67 TRIOLEX HE# APOPTONE HE# 67 ULORIC 67 Keryx Biopharma 67 Reports Preclinical Data 67 IONSYS TM 67 Glatiramer acetate 67 Aloxi ® 67 OPAXIO TM 67 lapatinib Tykerb 67 AZILECT ® 67 opioid induced constipation OIC 67 Boxed Warnings 67 tigecycline 67 evaluating picoplatin 67 Antitumor 67 Pharmacokinetics PK 67 Combo Therapy 67 Inhalation Powder 67 Potent Antiviral Activity 67 Orally administered 67 Bevacizumab Avastin 67 CDP# 67 systemic fungal infections 67 Chronic Hepatitis C 67 ELADUR ™ 67 Ozurdex 67 Exforge HCT 67 Oral Formulation 67 Vitrasert ® 67 Oral Calcitonin 67 diclofenac Voltaren 67 R MSCRAMM 67 Bepreve TM 67 vinorelbine tartrate 67 IMA# 67 Forodesine HCl 67 IMiDs ® 67 Luteinizing Hormone Releasing Hormone 67 Relapsed Refractory 67 FEMALES SHOULD BE ADVISED 67 Cilostazol 67 Ozarelix 67 adenosine injection 67 Aztreonam 67 R bisoprolol Euthyrox 67 OncoVex 67 induce orthostatic hypotension 67 Itraconazole 67 Improves Outcomes 67 Afatinib 67 oxymorphone ER 67 sodium thiosulfate STS 67 angiotensin II receptor blocker 67 Rotavirus Vaccine 67 Thiovir 67 Gets FDA Clearance 67 REVLIMID ®